Carbohydrate-based cancer vaccines: target cancer with sugar bullets
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Carbohydrate-based cancer vaccines: target cancer with sugar bullets
Authors
Keywords
-
Journal
GLYCOCONJUGATE JOURNAL
Volume 29, Issue 5-6, Pages 259-271
Publisher
Springer Nature
Online
2012-07-24
DOI
10.1007/s10719-012-9399-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The entirely carbohydrate immunogen Tn-PS A1 induces a cancer cell selective immune response and cytokine IL-17
- (2012) Ravindra A. De Silva et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants
- (2012) Colleen Olive Expert Review of Vaccines
- Monoclonal antibodies for the treatment of cancer
- (2012) Casey W. Shuptrine et al. SEMINARS IN CANCER BIOLOGY
- Carbohydrate-Monophosphoryl Lipid A Conjugates Are Fully Synthetic Self-Adjuvanting Cancer Vaccines Eliciting Robust Immune Responses in the Mouse
- (2011) Qianli Wang et al. ACS Chemical Biology
- Synthetic Antitumor Vaccines Containing MUC1 Glycopeptides with Two Immunodominant Domains-Induction of a Strong Immune Response against Breast Tumor Tissues
- (2011) Nikola Gaidzik et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Immunization with N-propionyl polysialic acid–KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci
- (2011) Lee M. Krug et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Synthesis of a MUC1-glycopeptide–BSA conjugate vaccine bearing the 3′-deoxy-3′-fluoro-Thomsen–Friedenreich antigen
- (2011) Anja Hoffmann-Röder et al. CHEMICAL COMMUNICATIONS
- Towards a Fully Synthetic MUC1-Based Anticancer Vaccine: Efficient Conjugation of Glycopeptides with Mono-, Di-, and Tetravalent Lipopeptides Using Click Chemistry
- (2011) Hui Cai et al. CHEMISTRY-A EUROPEAN JOURNAL
- Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention
- (2011) T. W. H. Flinsenberg et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines
- (2011) Cheryl Lai-Lai Chiang et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Synthesis of fluorinated Thomsen–Friedenreich antigens: direct deoxyfluorination of αGalNAc-threonine tert-butyl esters
- (2011) Manuel Johannes et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
- (2011) V. Lakshminarayanan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic cancer vaccines: Why so few randomised phase III studies reflect the initial optimism of phase II studies
- (2011) Angus G. Dalgleish VACCINE
- Cancer vaccines and carbohydrate epitopes
- (2011) Jamie Heimburg-Molinaro et al. VACCINE
- Synthetic and Immunological Studies of sTn Derivatives Carrying Substituted Phenylacetylsialic Acids as Cancer Vaccine Candidate
- (2011) Qianli Wang et al. ACS Medicinal Chemistry Letters
- Enhancement of the Immunogenicity of Synthetic Carbohydrate Vaccines by Chemical Modifications of STn Antigen
- (2010) Fan Yang et al. ACS Chemical Biology
- Synthetic Antitumor Vaccines from Tetanus Toxoid Conjugates of MUC1 Glycopeptides with the Thomsen-Friedenreich Antigen and a Fluorine-Substituted Analogue
- (2010) Anja Hoffmann-Röder et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Fluorinated Glycosyl Amino Acids for Mucin-Like Glycopeptide Antigen Analogues
- (2010) Sarah Wagner et al. CHEMISTRY-A EUROPEAN JOURNAL
- Translating Tumor Antigens into Cancer Vaccines
- (2010) Luigi Buonaguro et al. Clinical and Vaccine Immunology
- Identification and functions of pattern-recognition receptors
- (2010) Yutaro Kumagai et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape
- (2010) Robert L. Ferris et al. JOURNAL OF CLINICAL ONCOLOGY
- Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Delivers Heat Shock Protein 60-Fused Antigen into the MHC Class I Presentation Pathway
- (2010) J. Xie et al. JOURNAL OF IMMUNOLOGY
- Synthesis of a Single-Moleculel-Rhamnose-Containing Three-Component Vaccine and Evaluation of Antigenicity in the Presence of Anti-l-Rhamnose Antibodies
- (2010) Sourav Sarkar et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Carbohydrate vaccines: developing sweet solutions to sticky situations?
- (2010) Rena D. Astronomo et al. NATURE REVIEWS DRUG DISCOVERY
- Nanoparticle Delivery Systems in Cancer Vaccines
- (2010) Yogita Krishnamachari et al. PHARMACEUTICAL RESEARCH
- Synthesis of N-modified sTn analogs and evaluation of their immunogenicities by microarray-based immunoassay
- (2010) Sk Sahabuddin et al. TETRAHEDRON
- A Synthetic Vaccine Consisting of a Tumor-Associated Sialyl-TN-MUC1 Tandem-Repeat Glycopeptide and Tetanus Toxoid: Induction of a Strong and Highly Selective Immune Response
- (2009) Anton Kaiser et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
- (2009) Celestia S. Higano et al. CANCER
- Complement and its role in innate and adaptive immune responses
- (2009) Jason R Dunkelberger et al. CELL RESEARCH
- Increasing the Antigenicity of Synthetic Tumor-Associated Carbohydrate Antigens by Targeting Toll-Like Receptors
- (2009) Sampat Ingale et al. CHEMBIOCHEM
- Immunotherapy for cancer: synthetic carbohydrate-based vaccines
- (2009) Therese Buskas et al. CHEMICAL COMMUNICATIONS
- Recent development in carbohydrate-based cancer vaccines
- (2009) Zhongwu Guo et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Therapeutic vaccines in solid tumours: Can they be harmful?
- (2009) Alexander M.M. Eggermont EUROPEAN JOURNAL OF CANCER
- Immunological Response from an Entirely Carbohydrate Antigen: Design of Synthetic Vaccines Based on Tn−PS A1 Conjugates
- (2009) Ravindra A. De Silva et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Immune Therapy for Cancer
- (2008) Michael Dougan et al. Annual Review of Immunology
- Synthetic and Immunological Studies of5′-N-Phenylacetyl sTn to Develop Carbohydrate-Based Cancer Vaccines and to Explore the Impacts of Linkage between Carbohydrate Antigens and Carrier Proteins
- (2008) Qianli Wang et al. BIOCONJUGATE CHEMISTRY
- Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines
- (2008) Tanja D. de Gruijl et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes
- (2008) Ilham Bettahi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
- (2008) C. R. Casella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Synthesis and Immunochemical characterization ofS-linked Glycoconjugate Vaccines againstCandida albicans
- (2008) Xiangyang Wu et al. CHEMISTRY-A EUROPEAN JOURNAL
- Dendritic cell vaccines in melanoma: From promise to proof?
- (2008) W.J. Lesterhuis et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation
- (2008) Ayesha Murshid et al. Expert Review of Vaccines
- Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines
- (2008) Masahisa Jinushi et al. IMMUNOLOGICAL REVIEWS
- Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group
- (2008) Alessandro Testori et al. JOURNAL OF CLINICAL ONCOLOGY
- An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial
- (2008) Christopher Wood et al. LANCET
- Microbial carbohydrate depolymerization by antigen-presenting cells: Deamination prior to presentation by the MHCII pathway
- (2008) Jinyou Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started